AstraZeneca has warned it could relocate its vaccine manufacturing site on Merseyside to Philadelphia amid a deadlock in negotiations with the Labour government over plans to cut state aid promised to the project.
People briefed on the government’s thinking said chancellor Rachel Reeves wants to reduce the amount of state support provided to the British pharmaceutical company’s vaccine centre, cutting a pledge made by the last Conservative administration from about ￡90mn to ￡40mn.
The previous offer included up to ￡70mn in grants to develop an existing AstraZeneca vaccine facility at Speke, as well as ￡20mn in research and development support from the UK Health Security Agency, according to people briefed on the matter.
您已閱讀21%（727字），剩余79%（2769字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。